Search Results

You are looking at 1 - 8 of 8 items for :

  • Fluorouracil x
Clear All
Open access

Angelo Paci, Ségolène Hescot, Atmane Seck, Christel Jublanc, Lionel Mercier, Delphine Vezzosi, Delphine Drui, Marcus Quinkler, Martin Fassnacht, Eric Bruckert, Marc Lombès, Sophie Leboulleux, Sophie Broutin and Eric Baudin

performed using Unicel DXC Beckman Coulter Automate (Marseille, France). EP, etoposide-platin; F, fluorouracil; G, gemcitabine; PD, progressive disease; SD, stable disease. Investigation Influence of HCH and HTG on plasma o,p′ -DDD and o

Open access

Christopher Muir, Anthony Dodds and Katherine Samaras

femoral condyle. At age 33 years, a tubular adenocarcinoma of the rectum was detected, managed with low anterior resection and cautious adjuvant 5-fluorouracil chemotherapy. Anatomical pathology showed evidence of intramural and extramural spread

Open access

Marina Tsoli, Anna Angelousi, Dimitra Rontogianni, Constantine Stratakis and Gregory Kaltsas

inoperable, and there is no specific therapeutic regimen for parathyroid carcinomas FOLFOX (folic acid, Fluorouracil, Oxaliplatin) chemotherapy was initiated. After three cycles, the patient was found to have stable disease that was regarded as a response

Open access

Avital Nahmias, Simona Grozinsky-Glasberg, Asher Salmon and David J Gross

streptozocin, dischlorodiammine platinum (DDP), and 5 fluorouracil (5-FU) resulted in resolution of the hypoglycemia and marked regression of the hepatic lesions. However, 18 months later the disease progressed, and despite the administration of salvage PRRT

Open access

Sakshi Jhawar, Rahul Lakhotia, Mari Suzuki, James Welch, Sunita K Agarwal, John Sharretts, Maria Merino, Mark Ahlman, Jenny E Blau, William F Simonds and Jaydira Del Rivero

BR, biochemical response; mo, months; SR, symptomatic response. For ovarian NET patients progressing on novel therapies, chemotherapy can be used as a salvage option. Multiple agents including streptozocin, doxorubicin, 5-fluorouracil (5-FU

Open access

Tu Vinh Luong, Zaibun Nisa, Jennifer Watkins and Aimee R Hayes

-based studies have shown that patients with early-stage MMR-deficient colorectal adenocarcinomas have a more favourable prognosis than those with MMR-proficient tumours ( 11 ). Furthermore, there is evidence of lack of benefit of 5-fluorouracil-based adjuvant

Open access

Sally K Abell, Jessie Teng, Anthony Dowling, Michael S Hofman, Richard J MacIsaac and Nirupa Sachithanandan

-fluorouracil (5-FU). Outcome and follow-up The patient underwent four cycles of induction PRRT. The second cycle was complicated by an upper gastrointestinal bleed in the setting of persistent hypergastrinaemia, despite medical therapy with proton pump

Open access

Ali A Zaied, Halis K Akturk, Richard W Joseph and Augustine S Lee

, fluorouracil, oxaliplatin NR NR  ( 57 ) 58 M Melanoma DKA 62 days 6.8 None Ipilimumab NR NR *Systemic steroids were used for reasons other than autoimmune diabetes (colitis and adrenal insufficiency); † systemic